Shield Therapeutics (GB:STX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shield Therapeutics has launched a RetailBook Offer, allowing existing UK shareholders to purchase new ordinary shares at a premium price of 3.0p per share, raising up to £1 million. This offer is available through partners like AJ Bell and Hargreaves Lansdown and can be accessed using ISAs or SIPPs. The offer closes on December 20, 2024, with no commission charged by RetailBook.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.